{"grounding": "Osteoclasts are multinucleated cells with the unique ability to resorb bone matrix. Excessive production or activation of osteoclasts leads to skeletal pathologies that affect a significant portion of the population. Although therapies that effectively target osteoclasts have been developed, they are associated with sometimes severe side effects, and a fuller understanding of osteoclast biology may lead to more specific treatments. Along those lines, a rich body of work has defined essential signaling pathways required for osteoclast formation, function, and survival. Nonetheless, recent studies have cast new light on long-held views regarding the origin of these cells during development and homeostasis, their life span, and the cellular sources of factors that drive their production and activity during homeostasis and disease. In this review, we discuss these new findings in the context of existing work and highlight areas of ongoing and future investigation.", "generated_text": "Osteoclasts are specialized, multinucleated cells responsible for the dynamic process of bone resorption, a critical component of bone remodeling. Through the coordinated action of various signaling pathways, osteoclastogenesis is triggered, leading to the formation of mature osteoclasts. These cells utilize a range of enzymes and matrix metalloproteinases to degrade the organic and inorganic components of bone, resulting in osteolysis. The precise regulation of osteoclast activity is essential to maintain bone homeostasis, as excessive or impaired bone resorption can lead to various pathologies, including osteoporosis and bone cancer. Recent studies have elucidated the complex interplay between osteoclasts and their microenvironment, highlighting the importance of osteoclast-osteoblast interactions in regulating bone remodeling. Understanding the molecular mechanisms underlying osteoclast function and regulation is crucial for the development of novel therapeutic strategies to treat bone-related disorders.", "label": 1}